Search Results - "Basso U"

Safety and activity of sunitinib in elderly patients (≥70 years) with metastatic renal cell carcinoma: a multicenter study.

Authors: Brunello, A. Basso, U. Sacco, C. et al.

Source: Annals of Oncology. Feb2013, Vol. 24 Issue 2, p336-342. 7p. 3 Charts, 3 Graphs.

Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.

Authors: Brunello A Basso U Rossi E et al.

Source: Drugs & Aging. 2007, Vol. 24 Issue 11, p967-973. 7p.

URL: 27615667

Multidimensional geriatric evaluation in elderly cancer patients: a practical approach.

Authors: Basso, U. Monfardini, S.

Source: European Journal of Cancer Care. Dec2004, Vol. 13 Issue 5, p424-433. 10p.

Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma

Authors: Basso, U. Brandes, A.A.

Source: European Journal of Cancer. Jul2002, Vol. 38 Issue 10, p1298. 15p.

This result is not displayed to guests.
Login for full access.

1604P Aggregated analysis of treatment and survival outcome of all metastatic renal cell carcinoma patients treated from 2014 to 2018 in the Veneto region, Italy.

Authors: Basso, U. Tognazzo, S. Bortolami, A. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS966-S967. 2p.

Adjuvant! Online or comprehensive geriatric assessment for women over 70 years with primary breast cancer?

Authors: Monfardini, S Basso, U Fiduccia, P et al.

Source: British Journal of Cancer. 3/13/2012, Vol. 106 Issue 6, p1247-1247. 1p.

721P Ipilimumab and nivolumab compassionate use program in metastatic renal cell carcinoma patients with intermediate or poor IMDC risk score: The large multicenter Italian study.

Authors: Basso, U. Paolieri, F. Porta, C.G. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS566-S566. 1p.

SC170 - Phase 3 study of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (MHSPC): The ARCHES trial.

Authors: Basso, U. Galetti, T. Prayer Armstrong, A. et al.

Source: European Urology Supplements. Oct2019, Vol. 18 Issue 9, pe3258-e3258. 1p.

1051P Clinical outcomes of clinical stage I (CSI) elderly patients (pts) affected by germ-cell tumors (GCTs): A retrospective multicentric study (IGG07 trial).

Authors: Nuzzo, A. Marmiroli, A. Basso, U. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS707-S707. 1p.

More on sunitinib 2 weeks on/1 week off schedule: the Rainbow analysis.

Authors: Basso, U. Maruzzo, M.

Source: Annals of Oncology. Jan2016, Vol. 27 Issue 1, p202-203. 2p.

Video killed the Macintosh star: the definitive risk management experience of E. Profili Hospital in Fabriano on routine pediatric videolaryngoscopy.

Authors: Pisello, E. Ciuffreda, M. Silvestri, J. et al.

Source: Pediatric Anesthesia & Critical Care Journal (PACCJ). 2023, Vol. 11 Issue 1, p23-34. 12p.

Anesthesiological management of adenotonsillar surgery in pediatric setting: the experience of the Spoke Center E. Profili in Fabriano.

Authors: Silvestri, J. Ciuffreda, M. Pisello, E. et al.

Source: Pediatric Anesthesia & Critical Care Journal (PACCJ). 2022, Vol. 10 Issue 2, p56-62. 7p.

Preliminary study: routine use of videolaryngoscopy as a clinical risk mitigator in tracheal intubation of pediatric patients. The risk management experience of E. Profili Hospital in Fabriano.

Authors: Pisello, E. Ciuffreda, M. Silvestri, J. et al.

Source: Pediatric Anesthesia & Critical Care Journal (PACCJ). 2022, Vol. 10 Issue 1, p22-31. 10p.

A challenging case of Francisella Tularensis: teenager's massive lymphoadenopathy caused by an uncommon infectious disease.

Authors: Castellana, G. Ciuffreda, M. Pisello, E. et al.

Source: Pediatric Anesthesia & Critical Care Journal (PACCJ). 2022, Vol. 10 Issue 1, p32-36. 5p.

P4 Is vulnerable elders survey 13 (VES-13) a sensitive and specific screening tool for identifying vulnerable/frail elderly cancer patients compared to full comprehensive geriatric assessment (CGA)?

Authors: Falci, C. Basso, U. Fiduccia, P. et al.

Source: Critical Reviews in Oncology/Hematology. Oct2009 Supplement 1, Vol. 72, pS19-S20. 0p.

Analysis of tolerability and efficacy of sunitinib in elderly patients (≥ 70 years) wit metastatic renal cell carcinoma (mRCC)

Authors: Basso, U. Brunello, A. Sacco, C. et al.

Source: Critical Reviews in Oncology/Hematology. Oct2008 Supplement 2, Vol. 68, pS46-S46. 1p.

1655P Association of location of BRCA1/2 pathogenic variants with benefit from PARP-inhibitors in metastatic castration-resistant prostate cancers: Results from the PROGRESS study.

Authors: Incorvaia, L. Maruzzo, M. Basso, U. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS998-S998. 1p.

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.

Authors: Siefker-Radtke, A.O. Matsubara, N. Park, S.H. et al.

Source: Annals of Oncology. Jan2024, Vol. 35 Issue 1, p107-117. 11p.

Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy.

Authors: Santoro, A. Comandone, A. Basso, U. et al.

Source: Annals of Oncology. Apr2013, Vol. 24 Issue 4, p1093-1098. 6p.